Tombot, Inc.

Tombot, Inc. specializes in creating robotic emotional support animals, enhancing the well-being of individuals, especially the elderly, through innovative technology that combats loneliness and provides companionship. Founded in 2017 in Santa Clarita, US, Tombot, Inc. develops robotic therapy animals, including its flagship product, Jennie.

The firm has completed 3 deals, with the latest being a Series A round. In June 2025, Tombot raised USD 6. 1 mn led by Caduceus Capital Partners, bringing the total amount raised to USD 12. 2 mn and valuing the company at USD 31.

36 mn. Tombot, Inc. specializes in the development and sale of robotic emotional support animals, notably their flagship product, Jennie, a robotic therapy dog designed to provide companionship and alleviate feelings of loneliness in individuals, particularly the elderly and those in memory care facilities. These robotic pets simulate the experience of having a live pet, offering a solution for users who cannot care for traditional pets due to health conditions or living arrangements.

The primary clientele includes nursing homes, assisted living facilities, and direct consumers who seek emotional support for personal health challenges, such as dementia or anxiety disorders. The company targets markets in North America and Europe, focusing on regions with a high demand for innovative care solutions that cater to the emotional and mental well-being of aging populations. Tombot's revenue model is centered around direct-to-consumer sales and partnerships with healthcare facilities. Clients typically purchase the robotic animals outright, with a minimum investment requirement for larger-scale partnerships potentially being waived at the company's discretion.

The average transaction involves clients purchasing the robotic dogs, with pricing reflecting the advanced technology and emotional support capabilities embedded within the products. By positioning itself in both the consumer and B2B markets, Tombot aims to foster relationships with healthcare providers who see value in integrating robotic pets into their care programs, thus enhancing the emotional health of their residents while providing a unique offering that addresses both companionship and therapeutic needs. In June 2025, Tombot, Inc. raised USD 6.

1 mn in Series A funding, led by Caduceus Capital Partners. This funding will support the company's growth and manpower expansion. Tombot plans to enhance its product line with new robotic therapy animals designed for different user needs, and to expand its market reach into additional regions across Europe by 2026, targeting areas with significant elderly populations.